Quantitative cardiac dual source CT; from morphology to function

Cardiovascular diseases are a large contributor to the global mortality rate. Non-invasive imaging techniques, such as computed tomography (CT) imaging, have been playing a growing role in the risk assessment, diagnosis, and prognosis of coronary artery disease (CAD). One of the main challenges in the evaluation of CAD is the establishment of the optimal workflow to evaluate the anatomical as well as the functional aspects of CAD in all phases of the ischemic cascade.The research described in this thesis investigates the possibilities of CT to perform both morphological and functional evaluation of CAD and it is debated whether CT can be used clinically for the visualization of the entire ischemic cascade.Results show that the diagnostic and prognostic value of CT procedures for coronary artery disease evaluation can be improved by adding additional functional information to the anatomical evaluation. This was concluded from research done on two new technologies analyzing the blood flow through the coronaries and through the heart muscle. Besides that, important questions regarding protocol optimization and standardization have been investigated. Although CT shows great potential for the evaluation of CAD, the clinical workflow and combination of techniques to be used is yet to be optimized. Automating processes, for example with the use of Artificial Intelligence (AI), can enhance the clinical implementation and can help the field of cardiac radiology deal with the increased demand for cardiac imaging

Beyond the Artificial Intelligence Hype What Lies Behind the Algorithms and What We Can Achieve

The field of artificial intelligence (AI) is currently experiencing a period of extensive growth in a wide variety of fields, medicine not being the exception. The base of AI is mathematics and computer science, and the current fame of AI in industry and research stands on 3 pillars: big data, high performance computing infrastructure, and algorithms. In the current digital era, increased storage capabilities and data collection systems, lead to a massive influx of data for AI algorithm. The size and quality of data are 2 major factors influencing performance of AI applications. However, it is highly dependent on the type of task at hand and algorithm chosen to perform this task. AI may potentially automate several tedious tasks in radiology, particularly in cardiothoracic imaging, by pre-readings for the detection of abnormalities, accurate quantifications, for example, oncologic volume lesion tracking and cardiac volume and image optimization. Although AI-based applications offer great opportunity to improve radiology workflow, several challenges need to be addressed starting from image standardization, sophisticated algorithm development, and large-scale evaluation. Integration of AI into the clinical workflow also needs to address legal barriers related to security and protection of patient-sensitive data and liability before AI will reach its full potential in cardiothoracic imaging

Low CT temporal sampling rates result in a substantial underestimation of myocardial blood flow measurements

The purpose of this study was to evaluate the effect of temporal sampling rate in dynamic CT myocardial perfusion imaging (CTMPI) on myocardial blood flow (MBF). Dynamic perfusion CT underestimates myocardial blood flow compared to PET and SPECT values. For accurate quantitative analysis of myocardial perfusion with dynamic perfusion CT a stable calibrated HU measurement of MBF is essential. Three porcine hearts were perfused using an ex-vivo Langendorff model. Hemodynamic parameters were monitored. Dynamic CTMPI was performed using third generation dual source CT at 70 kVp and 230-350 mAs/rot in electrocardiography(ECG)-triggered shuttle-mode (sampling rate, 1 acquisition every 2-3 s; z-range, 10.2 cm), ECG-triggered non-shuttle mode (fixed table position) with stationary tube rotation (1 acquisition every 0.5-1 s, 5.8 cm), and non-ECG-triggered continuous mode (1 acquisition every 0.06 s, 5.8 cm). Stenosis was created in the circumflex artery, inducing different fractional flow reserve values. Volume perfusion CT Myocardium software was used to analyze ECG-triggered scans. For the non-ECG triggered scans MASS research version was used combined with an in-house Matlab script. MBF (mL/g/min) was calculated for non-ischemic segments. True MBF was calculated using input flow and heart weight. Significant differences in MBF between shuttle, non-shuttle and continuous mode were found, with median MBF of 0.87 [interquartile range 0.72-1.00], 1.20 (1.07-1.30) and 1.65 (1.40-1.88), respectively. The median MBF in shuttle mode was 56% lower than the true MBF. In non-shuttle and continuous mode, the underestimation was 41% and 18%. Limited temporal sampling rate in standard dynamic CTMPI techniques contributes to substantial underestimation of true MBF

Evaluation of pericoronary adipose tissue attenuation on CT

Pericoronary adipose tissue (PCAT) is the fat deposit surrounding coronary arteries. Although PCAT is part of the larger epicardial adipose tissue (EAT) depot, it has different pathophysiological features and roles in the atherosclerosis process. While EAT evaluation has been studied for years, PCAT evaluation is a relatively new concept. PCAT, especially the mean attenuation derived from CT images may be used to evaluate the inflammatory status of coronary arteries non-invasively. The most commonly used measure, PCATMA, is the mean attenuation of adipose tissue of 3 mm thickness around the proximal right coronary artery with a length of 40 mm. PCATMA can be analyzed on a per-lesion, per-vessel or per-patient basis. Apart from PCATMA, other measures for PCAT have been studied, such as thickness, and volume. Studies have shown associations between PCATMA and anatomical and functional severity of coronary artery disease. PCATMA is associated with plaque components and high-risk plaque features, and can discriminate patients with flow obstructing stenosis and myocardial infarction. Whether PCATMA has value on an individual patient basis remains to be determined. Furthermore, CT imaging settings, such as kV levels and clinical factors such as age and sex affect PCATMA measurements, which complicate implementation in clinical practice. For PCATMA to be widely implemented, a standardized methodology is needed. This review gives an overview of reported PCAT methodologies used in current literature and the potential use cases in clinical practice.</p

Towards reference values of pericoronary adipose tissue attenuation:impact of coronary artery and tube voltage in coronary computed tomography angiography

Objectives: To determine normal pericoronary adipose tissue mean attenuation (PCATMA) values for left the anterior descending (LAD), left circumflex (LCX), and right coronary artery (RCA) in patients without plaques on coronary CT angiography (cCTA), taking into account tube voltage influence. Methods: This retrospective study included 192 patients (76 (39.6%) men; median age 49 years (range, 19–79)) who underwent cCTA with third-generation dual-source CT for the suspicion of CAD between 2015 and 2017. We selected patients without plaque on cCTA. PCATMA was measured semi-automatically on cCTA images in the proximal segment of the three main coronary arteries with 10 mm length. Paired t-testing was used to compare PCATMA between combinations of two coronary arteries within each patient, and one-way ANOVA testing was used to compare PCATMA in different kV groups. Results: The overall mean ± standard deviation (SD) PCATMA was − 90.3 ± 11.1 HU. PCATMA in men was higher than that in women: − 88.5 ± 10.5 HU versus − 91.5 ± 11.3 HU (p = 0.001). PCATMA of LAD, LCX, and RCA was − 92.4 ± 11.6 HU, − 88.4 ± 9.9 HU, and − 90.2 ± 11.4 HU, respectively. Pairwise comparison of the arteries showed significant difference in PCATMA: LAD and LCX (p < 0.001), LAD and RCA (p = 0.009), LCX and RCA (p = 0.033). PCATMA of the 70 kV, 80 kV, 90 kV, 100 kV, and 120 kV groups was − 95.6 ± 9.6 HU, − 90.2 ± 11.5 HU, − 87.3 ± 9.9 HU, − 82.7 ± 6.2 HU, and − 79.3 ± 6.8 HU, respectively (p < 0.001). Conclusions: In patients without plaque on cCTA, PCATMA varied by tube voltage, with minor differences in PCATMA between coronary arteries (LAD, LCX, RCA). PCATMA values need to be interpreted taking into account tube voltage setting. Key Points: • In patients without plaque on cCTA, PCATMAdiffers slightly by coronary artery (LAD, LCX, RCA). • Tube voltage of cCTA affects PCATMAmeasurement, with mean PCATMAincreasing linearly with increasing kV. • For longitudinal cCTA analysis of PCATMA, the use of equal kV setting is strongly recommended

Evaluation of the Performance of Coordinate Measuring Machines in the Industry, Using Calibrated Artefacts

AbstractThe coordinate measuring machines (CMM's) has given a new impulse in the field of geometrical and dimensional metrology. The CMM's in industrial environments have become an important resource for the quality systems, monitoring manufacturing processes, reduction errors during the manufacturing process, inspection of product specifications and in continuous quality improvement. However, there is a need to evaluate, through practical, fast, effective and low cost methods, the CMM metrological specifications. Using calibrated artefacts, able to reproduce the geometric elements frequently measured, it seeks to ensure stability of the functional and metrological characteristics between calibrations and simultaneously knowing the errors. With better monitoring of the control parameters it is possible evaluate and optimize the calibration set deadlines, timely detection of faults and failures, detect structural changes and changes in environmental conditions of the laboratories, thus seeking to conduct a more detailed assessment of the stability of metrological characteristics of a CMM in industrial environments

Focal pericoronary adipose tissue attenuation is related to plaque presence, plaque type, and stenosis severity in coronary CTA

Objectives To investigate the association of pericoronary adipose tissue mean attenuation (PCAT(MA)) with coronary artery disease (CAD) characteristics on coronary computed tomography angiography (CCTA). Methods We retrospectively investigated 165 symptomatic patients who underwent third-generation dual-source CCTA at 70kVp: 93 with and 72 without CAD (204 arteries with plaque, 291 without plaque). CCTA was evaluated for presence and characteristics of CAD per artery. PCAT(MA) was measured proximally and across the most severe stenosis. Patient-level, proximal PCAT(MA) was defined as the mean of the proximal PCAT(MA) of the three main coronary arteries. Analyses were performed on patient and vessel level. Results Mean proximal PCAT(MA) was -96.2 +/- 7.1 HU and -95.6 +/- 7.8HU for patients with and without CAD (p = 0.644). In arteries with plaque, proximal and lesion-specific PCAT(MA) was similar (-96.1 +/- 9.6 HU, -95.9 +/- 11.2 HU, p = 0.608). Lesion-specific PCAT(MA) of arteries with plaque (-94.7 HU) differed from proximal PCAT(MA) of arteries without plaque (-97.2 HU, p = 0.015). Minimal stenosis showed higher lesion-specific PCAT(MA) (-94.0 HU) than severe stenosis (-98.5 HU, p = 0.030). Lesion-specific PCAT(MA) of non-calcified, mixed, and calcified plaque was -96.5 HU, -94.6 HU, and -89.9 HU (p = 0.004). Vessel-based total plaque, lipid-rich necrotic core, and calcified plaque burden showed a very weak to moderate correlation with proximal PCAT(MA). Conclusions Lesion-specific PCAT(MA) was higher in arteries with plaque than proximal PCAT(MA) in arteries without plaque. Lesion-specific PCAT(MA) was higher in non-calcified and mixed plaques compared to calcified plaques, and in minimal stenosis compared to severe; proximal PCAT(MA) did not show these relationships. This suggests that lesion-specific PCAT(MA) is related to plaque development and vulnerability

Relationships of pericoronary and epicardial fat measurements in male and female patients with and without coronary artery disease

INTRODUCTION: Although pericoronary adipose tissue (PCAT) is a component of the epicardial adipose tissue (EAT) depot, they may have different associations to coronary artery disease (CAD). We explored relationships between pericoronary adipose tissue mean attenuation (PCAT MA) and EAT measurements in coronary CT angiography (CCTA) in patients with and without CAD. MATERIAL AND METHODS: CCTA scans of 185 non-CAD and 81 CAD patients (86.4% &gt;50% stenosis) were included and retrospectively analyzed. PCAT MA and EAT density/volume were measured and analyzed by sex, including associations with age, risk factors and tube voltage using linear regression models. RESULTS: In non-CAD and CAD, mean PCAT MA and EAT volume were higher in men than in women (non-CAD: -92.5 ± 10.6HU vs -96.2 ± 8.4HU, and 174.4 ± 69.1 cm 3 vs 124.1 ± 57.3 cm 3; CAD: -92.2 ± 9.0HU vs -97.4 ± 9.7HU, and 193.6 ± 62.5 cm 3 vs 148.5 ± 50.5 cm 3 (p &lt; 0.05)). EAT density was slightly lower in men than women in non-CAD (-96.4 ± 6.3HU vs -94.4 ± 5.5HU (p &lt; 0.05)), and similar in CAD (-98.2 ± 5.2HU vs 98.2 ± 6.4HU). There was strong correlation between PCAT MA and EAT density (non-CAD: r = 0.725, p &lt; 0.001, CAD: r = 0.686, p &lt; 0.001) but no correlation between PCAT MA and EAT volume (non-CAD: r = 0.018, p = 0.81, CAD: r = -0.055, p = 0.63). A weak inverse association was found between EAT density and EAT volume (non-CAD: r = -0.244, p &lt; 0.001, CAD: r = -0.263, p = 0.02). In linear regression models, EAT density was significantly associated with PCAT MA in both non-CAD and CAD patients independent of risk factors and tube voltage. CONCLUSION: In CAD and non-CAD patients, EAT density, but not EAT volume, showed significant associations with PCAT MA. Compared to women, men had higher PCAT MA and EAT volume independently of disease status, but similar or slightly lower EAT density. Differences in trends and relations of PCAT MA and EAT by sex could indicate that personalized interpretation and thresholding is needed. </p

Myocardial extracellular volume fraction to differentiate healthy from cardiomyopathic myocardium using dual-source dual-energy CT

Objective: To evaluate the feasibility of dual-energy CT (DECT)-based iodine quantification to estimate myocardial extracellular volume (ECV) fraction in patients with and without cardiomyopathy (CM), as well as to assess its ability to distinguish healthy myocardial tissue from cardiomyopathic, with the goal of defining a threshold ECV value for disease detection. Methods: Ten subjects free of heart disease and 60 patients with CM (mean age 66.4 ± 9.4; 59 males and 11 females; 40 ischemic and 20 non-ischemic CM) underwent late iodine enhanced DECT imaging. Myocardial iodine maps were obtained using 3-material decomposition. ECV of the left ventricle was estimated from hematocrit levels and the iodine maps using the AHA 16-segment model. Receiver operating characteristic curve analysis was performed, with corresponding area under the curve, along with Youden's index assessment, to establish a threshold for CM detection. Results: The median ECV for healthy myocardium, non-ischemic CM, and ischemic CM were 25.4% (22.9–27.3), 38.3% (33.7–43.0), and 36.9% (32.4–41.1), respectively. Healthy myocardium showed significantly lower ECV values compared to ischemic and non-ischemic CM (p 29.5% would indicate the presence of CM in the myocardium (sensitivity = 90.3; specificity = 90.3); the AUC for this criterion was 0.950 (p < 0.001). Conclusion: The findings of this study resulted in a statistically significant distinction between healthy myocardium and CM ECVs. This led to the establishment of a promising threshold ECV value that could facilitate the differentiation between healthy and diseased myocardium, and highlights the potential of this DECT methodology to detect cardiomyopathic tissue

Non-invasive fractional flow reserve (FFRCT) in the evaluation of acute chest pain ? Concepts and first experiences

Objective: To evaluate 30 day rate of major adverse cardiac events (MACE) utilizing cCTA and FFRCT for evaluation of patients presenting to the Emergency Department (ED) with acute chest pain. Materials and methods: Patients between the ages of 18?95 years who underwent clinically indicated cCTA and FFRCT in the evaluation of acute chest pain in the emergency department were retrospectively evaluated for 30 day MACE, repeat presentation/admission for chest pain, revascularization, and additional testing. Results: A total of 59 patients underwent CCTA and subsequent FFRCT for the evaluation of acute chest pain in the ED over the enrollment period. 32 out of 59 patients (54 %) had negative FFRCT (>0.80) out of whom 18 patients (55 %) were discharged from the ED. Out of the 32 patients without functionally significant CAD by FFRCT, 32 patients (100 %) underwent no revascularization and 32 patients (100 %) had no MACE at the 30-day follow-up period. Conclusion: In this limited retrospective study, patients presenting to the ED with acute chest pain and with CCTA with subsequent FFRCT of >0.8 had no MACE at 30 days; however, for many of these patients results were not available at time of clinical decision making by the ED physician